Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (3): 302-308.

Previous Articles     Next Articles

Clinical application of monitoring thiopurine methyltransferase gene polymorphism and 6-thioguanine nucleotides concentration in red blood cells on inflammatory bowel disease patients with azathioprine treatment

XIA Quan1,3, HUANG Yan1, WANG Yan-yan1, XU Du-juan1, HU Nai-zhong2, HU Jing2, MEI Qiao2, CHEN Fei-hu3   

  1. 1Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China;
    2Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China;
    3School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China
  • Received:2013-03-19 Revised:2014-01-16 Online:2014-03-26 Published:2014-04-10

Abstract: AIM: To investigate the clinical application of monitoring TPMT gene polymorphism and 6-TGNs concentration on inflammatory bowel disease (IBD) patients with azathioprine treatment, so as to implementing individual dosage regimen.METHODS: Patients diagnosed with IBD were met the inclusion criteria, the TPMT*3 genotyping assay was based on polymerase chain reaction and Pyrosequencing for TPMT exon 7 (G460A) and TPMT exon 10 (A719G). The concentrations of 6-TGNs in red blood cells were measured by high-performance liquid chromatography.RESULTS: For 15 patients, TPMT*3 genotyping were wild type and no mutation was found. The initial concentrations of 6-TGNs were 147.31-875.26 pmol per 8×108 RBC and significant individual differences were obvious for patients with same dose azathioprine.CONCLUSION: TPMT genotyping is useful to predict the myelosuppression, while 6-TGNs monitoring is helpful to adjusting dose of azathioprine. Application of combining TPMP genotyping and 6-TGNs monitor may offer a basis for individualized and safe medication for IBD patients.

Key words: inflammatory bowel disease, thiopurine methyltransferase gene polymorphism, 6-TGNs concentration in red blood cells, clinical application

CLC Number: